Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NEUROONE MEDICAL TECHNOLOGIES CorpNMTC · Entity 7808 | Director | April 03, 2026 | April 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NEUROONE MEDICAL TECHNOLOGIES Corp
Report date April 03, 2026 · Filed April 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 133,932 |
Reported balance
After 2026-04-03 transaction · row 1
1 source rowRow 1 · 2026-04-03 · Grant · Acquired 41,929 · Balance 133,932 F1: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.80 · Expires 2036-04-02 | Direct | 26,036 |
Reported balance
After 2026-04-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-04-03 · Grant · Acquired 26,036 · Balance 26,036 F2: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.
F2: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
LivaNova PLC
Report date January 01, 2020 · Filed January 07, 2020
Section 16 reporting ended · disclosed 2020-01-07. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 03, 2026 Filed Apr 7, 2026 17:22 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | GrantOption to Purchase Common Stock · Derivative | 26,036 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001656026-26-000003 · primary_doc.xml · derivative · entry 2 Andrle Edward · CIK 0001656026 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,036 Underlying: Common Stock · 26,036 shares Expires 2036-04-02 F2 · derivative.exercise_date: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. Read SEC document |
| April 03, 2026 Filed Apr 7, 2026 17:22 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | GrantCommon Stock | 41,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001656026-26-000003 · primary_doc.xml · nonDerivative · entry 1 Andrle Edward · CIK 0001656026 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,932 F1 · shares: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. Read SEC document |
| June 23, 2025 Filed Jun 25, 2025 19:34 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | GrantOption to Purchase Common Stock · Derivative | 50,000 | $0.00 Strike: $0.66 | $0.00 |
DisclosureSEC source: 0001656026-25-000002 · primary_doc.xml · derivative · entry 1 Andrle Edward · CIK 0001656026 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-06-23 F1 · derivative.exercise_date: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 17:06 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | GrantOption to Purchase Common Stock · Derivative | 17,025 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001656026-25-000001 · primary_doc.xml · derivative · entry 2 Andrle Edward · CIK 0001656026 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,025 Underlying: Common Stock · 17,025 shares Expires 2035-02-14 F2 · derivative.exercise_date: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 17:06 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | GrantCommon Stock | 27,778 | $0.00 | $0.00 |
DisclosureSEC source: 0001656026-25-000001 · primary_doc.xml · nonDerivative · entry 1 Andrle Edward · CIK 0001656026 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,003 F1 · shares: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. Read SEC document |
| March 16, 2023 Filed Mar 20, 2023 17:39 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | GrantOption to Purchase Common Stock · Derivative | 18,927 | $0.00 Strike: $1.62 | $0.00 |
DisclosureSEC source: 0001656026-23-000001 · primary_doc.xml · derivative · entry 2 Andrle Edward · CIK 0001656026 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,927 Underlying: Common Stock · 18,927 shares Expires 2033-03-16 F2 · derivative.exercise_date: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. Read SEC document |
| March 16, 2023 Filed Mar 20, 2023 17:39 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | GrantCommon Stock | 20,576 | $0.00 | $0.00 |
DisclosureSEC source: 0001656026-23-000001 · primary_doc.xml · nonDerivative · entry 1 Andrle Edward · CIK 0001656026 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,225 F1 · shares: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 20:02 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | GrantOption to Purchase Common Stock · Derivative | 29,230 | $0.00 Strike: $1.14 | $0.00 |
DisclosureSEC source: 0001656026-22-000001 · primary_doc.xml · derivative · entry 2 Andrle Edward · CIK 0001656026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,230 Underlying: Common Stock · 29,230 shares Expires 2032-05-31 F2 · derivative.exercise_date: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 20:02 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | GrantCommon Stock | 29,240 | $0.00 | $0.00 |
DisclosureSEC source: 0001656026-22-000001 · primary_doc.xml · nonDerivative · entry 1 Andrle Edward · CIK 0001656026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,649 F1 · shares: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 20:06 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | GrantOption to Purchase Common Stock · Derivative | 4,682 | $0.00 Strike: $7.26 | $0.00 |
DisclosureSEC source: 0001596771-21-000037 · primary_doc.xml · derivative · entry 2 Andrle Edward · CIK 0001656026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,682 Underlying: Common Stock · 4,682 shares Expires 2031-06-02 F3 · derivative.exercise_date: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 20:06 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | GrantCommon Stock | 4,592 | $0.00 | $0.00 |
DisclosureSEC source: 0001596771-21-000037 · primary_doc.xml · nonDerivative · entry 1 Andrle Edward · CIK 0001656026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,404 F1 · shares: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. F2 · balance_after: The share amount has been adjusted to reflect the reverse stock split effective on March 31, 2021 whereby each three shares of common stock issued and outstanding prior to the split were combined and converted into one share of common stock. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 21:07 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | GrantOption to Purchase Common Stock · Derivative | 23,725 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0001596771-20-000045 · primary_doc.xml · derivative · entry 2 Andrle Edward · CIK 0001656026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,725 Underlying: Common Stock · 23,725 shares Expires 2030-06-02 F2 · derivative.exercise_date: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 21:07 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | GrantCommon Stock | 22,371 | $0.00 | $0.00 |
DisclosureSEC source: 0001596771-20-000045 · primary_doc.xml · nonDerivative · entry 1 Andrle Edward · CIK 0001656026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,435 F1 · shares: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 21:55 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | GrantCommon Stock | 7,064 | $0.00 | $0.00 |
DisclosureSEC source: 0001596771-20-000008 · primary_doc.xml · nonDerivative · entry 1 Andrle Edward · CIK 0001656026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,064 F1 · shares: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. Read SEC document |
| October 18, 2019 Filed Oct 31, 2019 15:17 UTC | LivaNova PLC LIVN · Entity 507 | Exercise / conversionStock Appreciation Rights · Derivative | 29,718 | $0.00 Strike: $69.39 | $0.00 |
DisclosureSEC source: 0001639691-19-000146 · wf-form4_157253501542050.xml · derivative · entry 2 Andrle Edward · CIK 0001656026 · General Manager, NM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,513 Underlying: Ordinary Shares · 29,718 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Reporting person was granted an award of stock appreciation rights ("SARs"). Subject to the terms and conditions of the LivaNova PLC 2015 Incentive Award Plan (the "Plan") and the SAR Agreement, the SARs shall vest in equal installments of 25% on each of the four anniversaries of the grant date, October 19, 2015. F1 · derivative.expiration_date: Reporting person was granted an award of stock appreciation rights ("SARs"). Subject to the terms and conditions of the LivaNova PLC 2015 Incentive Award Plan (the "Plan") and the SAR Agreement, the SARs shall vest in equal installments of 25% on each of the four anniversaries of the grant date, October 19, 2015. Read SEC document |
| October 18, 2019 Filed Oct 31, 2019 15:17 UTC | LivaNova PLC LIVN · Entity 507 | Exercise / conversionOrdinary Shares | 29,718 | $69.39 | $2,062,132.02 |
DisclosureSEC source: 0001639691-19-000146 · wf-form4_157253501542050.xml · nonDerivative · entry 1 Andrle Edward · CIK 0001656026 · General Manager, NM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 18, 2019 Filed Nov 1, 2019 20:58 UTC Amendment | LivaNova PLC LIVN · Entity 507 | Exercise / conversionStock Appreciation Rights · Derivative | 29,718 | $0.00 Strike: $69.39 | $0.00 |
DisclosureSEC source: 0001639691-19-000147 · wf-form4a_157264189263445.xml · derivative · entry 3 Andrle Edward · CIK 0001656026 · General Manager, NM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,513 Underlying: Ordinary Shares · 29,718 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Reporting person was granted an award of SARs. Subject to the terms and conditions of the the Plan and the SAR Agreement, the SARs shall vest on the anniversary of the grant date, October 19, 2015. F2 · derivative.expiration_date: Reporting person was granted an award of SARs. Subject to the terms and conditions of the the Plan and the SAR Agreement, the SARs shall vest on the anniversary of the grant date, October 19, 2015. Read SEC document |
| October 18, 2019 Filed Nov 1, 2019 20:58 UTC Amendment | LivaNova PLC LIVN · Entity 507 | Tax withholdingOrdinary Shares | 28,447 | $74.66 | $2,123,853.02 |
DisclosureSEC source: 0001639691-19-000147 · wf-form4a_157264189263445.xml · nonDerivative · entry 2 Andrle Edward · CIK 0001656026 · General Manager, NM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,055 F1 · shares: Form 4 amended to show cashless exercise by the LivaNova PLC (the "Company") pursuant to the LivaNova PLC 2015 Incentive Award Plan (the "Plan") on the last business day prior to expiration of the stock appreciation rights ("SARs") whereby 28,447 shares were withheld from distribution to cover the purchase of shares and to satisfy tax liability. Read SEC document |
| October 18, 2019 Filed Nov 1, 2019 20:58 UTC Amendment | LivaNova PLC LIVN · Entity 507 | Exercise / conversionOrdinary Shares | 29,718 | $69.39 | $2,062,132.02 |
DisclosureSEC source: 0001639691-19-000147 · wf-form4a_157264189263445.xml · nonDerivative · entry 1 Andrle Edward · CIK 0001656026 · General Manager, NM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 20:42 UTC | LivaNova PLC LIVN · Entity 507 | GrantOrdinary Shares | 273 | $61.17 | $16,699.41 |
DisclosureSEC source: 0001639691-19-000113 · wf-form4_156210014104377.xml · nonDerivative · entry 1 Andrle Edward · CIK 0001656026 · General Manager, NM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,784 F1 · kind: These shares were acquired under the LivaNova Employee Stock Purchase Plan that are exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| May 05, 2019 Filed May 7, 2019 19:31 UTC | LivaNova PLC LIVN · Entity 507 | Exercise / conversionRestricted Stock Units · Derivative | 688 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-19-000074 · wf-form4_155725747879296.xml · derivative · entry 3 Andrle Edward · CIK 0001656026 · General Manager, NM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,534 Underlying: Ordinary Shares · 688 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive Ordinary Share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the Plan) and the award agreement. F4 · derivative.exercise_date: Reporting person was granted RSUs subject to a four-year vesting schedule, vesting 25% on each of the first four anniversaries of May 5, 2017, subject to continued service during the vesting period. F4 · derivative.expiration_date: Reporting person was granted RSUs subject to a four-year vesting schedule, vesting 25% on each of the first four anniversaries of May 5, 2017, subject to continued service during the vesting period. Read SEC document |
| May 05, 2019 Filed May 7, 2019 19:31 UTC | LivaNova PLC LIVN · Entity 507 | Tax withholdingOrdinary Shares | 271 | $74.77 | $20,262.67 |
DisclosureSEC source: 0001639691-19-000074 · wf-form4_155725747879296.xml · nonDerivative · entry 2 Andrle Edward · CIK 0001656026 · General Manager, NM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,511 F2 · shares: The referenced shares were withheld from distribution at the request of reporting person to satisfy tax liability. Read SEC document |
| May 05, 2019 Filed May 7, 2019 19:31 UTC | LivaNova PLC LIVN · Entity 507 | Exercise / conversionOrdinary Shares | 688 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-19-000074 · wf-form4_155725747879296.xml · nonDerivative · entry 1 Andrle Edward · CIK 0001656026 · General Manager, NM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,782 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares (Ordinary Shares) of LivaNova PLC (the Company), GBP 1.00 par value. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 20:06 UTC | LivaNova PLC LIVN · Entity 507 | GrantStock Appreciation Rights · Derivative | 5,903 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-19-000055 · wf-form4_155423558567525.xml · derivative · entry 4 Andrle Edward · CIK 0001656026 · General Manager, NM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,231 Underlying: Ordinary Shares · 5,903 shares Expires not disclosed F6 · derivative.exercise_price: 93.25 Conversion or Exercise Price of Derivative Security. F7 · derivative.exercise_date: Reporting person was granted an award of stock appreciation rights ("SARs"). Subject to the terms and conditions of the Plan and the SAR Agreement, the SARs shall vest in equal installments of 25% on each of the first four anniversaries of the grant date, March 29, 2019. F7 · derivative.expiration_date: Reporting person was granted an award of stock appreciation rights ("SARs"). Subject to the terms and conditions of the Plan and the SAR Agreement, the SARs shall vest in equal installments of 25% on each of the first four anniversaries of the grant date, March 29, 2019. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 20:06 UTC | LivaNova PLC LIVN · Entity 507 | GrantPerformance Stock Units · Derivative | 1,928 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-19-000055 · wf-form4_155423558567525.xml · derivative · entry 3 Andrle Edward · CIK 0001656026 · General Manager, NM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,222 Underlying: Ordinary Shares · 1,928 shares Expires not disclosed F3 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the Plan and the award agreement. F5 · derivative.exercise_date: On March 29, 2019, reporting person was granted 1,928 PSUs to vest or lapse on the filing of the Company's Annual Report on Form 10-K for the fiscal year ending December 31, 2021 based on how the Company's cumulative adjusted free cash flow for fiscal years 2019, 2020 and 2021 compares to a target determined by the Plan Administrator. The form of agreement for this award was filed with the Securities and Exchange Commission on April 1, 2019. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting. F5 · derivative.expiration_date: On March 29, 2019, reporting person was granted 1,928 PSUs to vest or lapse on the filing of the Company's Annual Report on Form 10-K for the fiscal year ending December 31, 2021 based on how the Company's cumulative adjusted free cash flow for fiscal years 2019, 2020 and 2021 compares to a target determined by the Plan Administrator. The form of agreement for this award was filed with the Securities and Exchange Commission on April 1, 2019. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 20:06 UTC | LivaNova PLC LIVN · Entity 507 | GrantPerformance Stock Units · Derivative | 1,928 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-19-000055 · wf-form4_155423558567525.xml · derivative · entry 2 Andrle Edward · CIK 0001656026 · General Manager, NM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,294 Underlying: Ordinary Shares · 1,928 shares Expires not disclosed F3 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the Plan and the award agreement. F4 · derivative.exercise_date: On March 29, 2019, reporting person was granted 1,928 PSUs to vest or lapse on the filing of the Company's Annual Report on Form 10-K for the fiscal year ending December 31, 2021 ("2021 Form 10-K") based on the rank of the Company's total shareholder return for the three-year period ending December 31, 2021 relative to the total shareholder return of a peer group of companies, as determined by the Plan Administrator. The form of agreement for this award was filed with the Securities and Exchange Commission in a Current Report on Form 8-K on April 1, 2019. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting. F4 · derivative.expiration_date: On March 29, 2019, reporting person was granted 1,928 PSUs to vest or lapse on the filing of the Company's Annual Report on Form 10-K for the fiscal year ending December 31, 2021 ("2021 Form 10-K") based on the rank of the Company's total shareholder return for the three-year period ending December 31, 2021 relative to the total shareholder return of a peer group of companies, as determined by the Plan Administrator. The form of agreement for this award was filed with the Securities and Exchange Commission in a Current Report on Form 8-K on April 1, 2019. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 20:06 UTC | LivaNova PLC LIVN · Entity 507 | GrantRestricted Stock Units · Derivative | 1,928 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-19-000055 · wf-form4_155423558567525.xml · derivative · entry 1 Andrle Edward · CIK 0001656026 · General Manager, NM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,366 Underlying: Ordinary Shares · 1,928 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one ordinary share (Ordinary Share) of LivaNova PLC (the Company), GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the Plan) and the award agreement. F2 · derivative.exercise_date: Reporting person was granted RSUs subject to a four-year vesting schedule, vesting 25% on each of the first four anniversaries of March 29, 2019, subject to continued service during the vesting period and the RSU Agreement. F2 · derivative.expiration_date: Reporting person was granted RSUs subject to a four-year vesting schedule, vesting 25% on each of the first four anniversaries of March 29, 2019, subject to continued service during the vesting period and the RSU Agreement. Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 21:09 UTC | LivaNova PLC LIVN · Entity 507 | Exercise / conversionRestricted Stock Units · Derivative | 1,131 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-19-000042 · wf-form4_155302978198243.xml · derivative · entry 6 Andrle Edward · CIK 0001656026 · General Manager, NM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,438 Underlying: Ordinary Shares · 1,131 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share (Ordinary Share) of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the Plan) and the award agreement. F5 · derivative.exercise_date: Reporting person was granted RSUs that vest and all forfeiture restrictions thereon shall lapse on March 15, 2019. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. F5 · derivative.expiration_date: Reporting person was granted RSUs that vest and all forfeiture restrictions thereon shall lapse on March 15, 2019. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 21:09 UTC | LivaNova PLC LIVN · Entity 507 | Exercise / conversionRestricted Stock Units · Derivative | 531 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-19-000042 · wf-form4_155302978198243.xml · derivative · entry 5 Andrle Edward · CIK 0001656026 · General Manager, NM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,569 Underlying: Ordinary Shares · 531 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share (Ordinary Share) of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the Plan) and the award agreement. F4 · derivative.exercise_date: Reporting person was granted RSUs subject to a four-year vesting schedule, vesting 25% on each of the first four anniversaries of March 15, 2018, subject to continued service during the vesting period. F4 · derivative.expiration_date: Reporting person was granted RSUs subject to a four-year vesting schedule, vesting 25% on each of the first four anniversaries of March 15, 2018, subject to continued service during the vesting period. Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 21:09 UTC | LivaNova PLC LIVN · Entity 507 | Tax withholdingOrdinary Shares | 275 | $95.84 | $26,356.00 |
DisclosureSEC source: 0001639691-19-000042 · wf-form4_155302978198243.xml · nonDerivative · entry 4 Andrle Edward · CIK 0001656026 · General Manager, NM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,094 F2 · shares: The referenced shares were withheld from distribution at the request of reporting person to satisfy tax liability. Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 21:09 UTC | LivaNova PLC LIVN · Entity 507 | Exercise / conversionOrdinary Shares | 1,131 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-19-000042 · wf-form4_155302978198243.xml · nonDerivative · entry 3 Andrle Edward · CIK 0001656026 · General Manager, NM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,369 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value. Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 21:09 UTC | LivaNova PLC LIVN · Entity 507 | Tax withholdingOrdinary Shares | 129 | $95.84 | $12,363.36 |
DisclosureSEC source: 0001639691-19-000042 · wf-form4_155302978198243.xml · nonDerivative · entry 2 Andrle Edward · CIK 0001656026 · General Manager, NM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,238 F2 · shares: The referenced shares were withheld from distribution at the request of reporting person to satisfy tax liability. Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 21:09 UTC | LivaNova PLC LIVN · Entity 507 | Exercise / conversionOrdinary Shares | 531 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-19-000042 · wf-form4_155302978198243.xml · nonDerivative · entry 1 Andrle Edward · CIK 0001656026 · General Manager, NM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,367 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value. Read SEC document |
| March 11, 2019 Filed Mar 14, 2019 00:28 UTC | LivaNova PLC LIVN · Entity 507 | Exercise / conversionRestricted Stock Units · Derivative | 5,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-19-000028 · wf-form4_155252327157751.xml · derivative · entry 3 Andrle Edward · CIK 0001656026 · General Manager, NM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,100 Underlying: Ordinary Shares · 5,208 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary shares (Ordinary Share) of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the Plan) and the award agreement. F4 · derivative.exercise_date: The reporting person was granted restricted stock units subject to a four-year vesting schedule, vesting 20% on, each, March 11, 2017, March 11, 2018 and March 11, 2019, and 40% on March 11, 2020. The restricted stock units are subject to forfeiture prior to vesting in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan. F4 · derivative.expiration_date: The reporting person was granted restricted stock units subject to a four-year vesting schedule, vesting 20% on, each, March 11, 2017, March 11, 2018 and March 11, 2019, and 40% on March 11, 2020. The restricted stock units are subject to forfeiture prior to vesting in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan. Read SEC document |
| March 11, 2019 Filed Mar 14, 2019 00:28 UTC | LivaNova PLC LIVN · Entity 507 | Tax withholdingOrdinary Shares | 1,268 | $94.87 | $120,295.16 |
DisclosureSEC source: 0001639691-19-000028 · wf-form4_155252327157751.xml · nonDerivative · entry 2 Andrle Edward · CIK 0001656026 · General Manager, NM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,836 F2 · shares: The referenced shares were withheld from distribution at the request of reporting person to satisfy tax liability. Read SEC document |
| March 11, 2019 Filed Mar 14, 2019 00:28 UTC | LivaNova PLC LIVN · Entity 507 | Exercise / conversionOrdinary Shares | 5,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-19-000028 · wf-form4_155252327157751.xml · nonDerivative · entry 1 Andrle Edward · CIK 0001656026 · General Manager, NM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,104 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:35 UTC | LivaNova PLC LIVN · Entity 507 | Exercise / conversionRestricted Stock Units · Derivative | 2,063 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-19-000020 · wf-form4_155182173742775.xml · derivative · entry 3 Andrle Edward · CIK 0001656026 · General Manager, NM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,308 Underlying: Ordinary Shares · 2,063 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share (Ordinary Share) of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the Plan) and the award agreement. F4 · derivative.exercise_date: On May 5, 2017, reporting person was granted RSUs that vest 25% on the second day after release of LivaNova's full-year 2018 financial results, February 27, 2019 (Measure Date), provided and to the extent that a market condition is achieved on the Measure Date. The market condition is a stock price that ranges between a threshold price, at which one-third of the RSUs become eligible for vesting and a target price, at which all of the RSUs become eligible for vesting, with the number of RSUs eligible for vesting at a price between the threshold price and the target price determined by linear interpolation. The number included in column 5 of Table II reflects the RSUs eligible for vesting at the target price. F4 · derivative.expiration_date: On May 5, 2017, reporting person was granted RSUs that vest 25% on the second day after release of LivaNova's full-year 2018 financial results, February 27, 2019 (Measure Date), provided and to the extent that a market condition is achieved on the Measure Date. The market condition is a stock price that ranges between a threshold price, at which one-third of the RSUs become eligible for vesting and a target price, at which all of the RSUs become eligible for vesting, with the number of RSUs eligible for vesting at a price between the threshold price and the target price determined by linear interpolation. The number included in column 5 of Table II reflects the RSUs eligible for vesting at the target price. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:35 UTC | LivaNova PLC LIVN · Entity 507 | Tax withholdingOrdinary Shares | 533 | $96.02 | $51,178.66 |
DisclosureSEC source: 0001639691-19-000020 · wf-form4_155182173742775.xml · nonDerivative · entry 2 Andrle Edward · CIK 0001656026 · General Manager, NM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,896 F2 · shares: The referenced shares were withheld from distribution at the request of reporting person to satisfy tax liability. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:35 UTC | LivaNova PLC LIVN · Entity 507 | Exercise / conversionOrdinary Shares | 2,063 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-19-000020 · wf-form4_155182173742775.xml · nonDerivative · entry 1 Andrle Edward · CIK 0001656026 · General Manager, NM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,429 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.